![](/img/cover-not-exists.png)
Initial results from a phase 1a/b study of OMP-131R10, a first-in-class anti-RSPO3 antibody, in advanced solid tumors and previously treated metastatic colorectal cancer (CRC)
Bendell, J., Eckhardt, G.S., Hochster, H.S., Morris, V.K., Strickler, J., Kapoun, A.M., Wang, M., Xu, L., McGuire, K., Dupont, J., Faoro, L., Munster, P.Volume:
69
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)32668-5
Date:
December, 2016
File:
PDF, 58 KB
english, 2016